Molecular characterization of Clostridioides difficile ribotype 027 in a major Chinese hospital

J Microbiol Immunol Infect. 2021 Dec;54(6):1179-1183. doi: 10.1016/j.jmii.2021.01.003. Epub 2021 Jan 28.

Abstract

Background: The rapid spread of C. difficile 027 has become one of the leading threats of healthcare-associated infections wordwild. However, C. difficile 027 infections have rarely been reported in China. The objective of this study was to strengthen the understanding of the molecular characterizations of C. difficile 027 in China.

Methods: In this study, stool specimens from 176 suspected CDI cases were collected from 1 Jan 2018 to 30 Jun 2019. These specimens were measured by GeneXpert test and C.difficile colonies were identified and analyzed.

Results: There were five samples positive for tcdA, tcdB, binary toxin genes and had deletions in tcdC gene. These five Clostridioides difficile isolates belonged to ST1 and confirmed as Clostridioides difficile 027 strains by PCR ribotyping. Through using whole genome sequencing, , we found that these five strains were closely clustered into the same predominant evolutionary branch and were highly similar to C. difficile 027 strain R20291. Antimicrobial susceptibility testing result showed they were highly resistant to fluoroquinolones.

Conclusions: In Our study, five C. difficile 027 isolates were identified and characterized using MLST, PCR ribotyping and whole genome sequencing. We proposed that C. difficile 027 infections are probably neglected in China. Further epidemiological studies across the country together with the introduction of routine diagnostic testing and multi-center or national level surveillance are needed to ascertain the size of this potentially significant problem.

Keywords: Antimicrobial resistance; China; Clostridioides difficile; Multilocus sequence typing; PCR RT027; Whole genome sequence.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • China / epidemiology
  • Clostridioides difficile / classification
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / genetics*
  • Clostridioides difficile / isolation & purification
  • Clostridium Infections / epidemiology
  • Clostridium Infections / microbiology*
  • Drug Resistance, Bacterial
  • Genome, Bacterial / genetics
  • Genotype
  • Hospitals
  • Humans
  • Microbial Sensitivity Tests
  • Multilocus Sequence Typing
  • Phylogeny
  • Retrospective Studies
  • Ribotyping

Substances

  • Anti-Bacterial Agents